vs

Side-by-side financial comparison of NewAmsterdam Pharma Co N.V. (NAMS) and SUNation Energy, Inc. (SUNE). Click either name above to swap in a different company.

SUNation Energy, Inc. is the larger business by last-quarter revenue ($27.2M vs $19.1M, roughly 1.4× NewAmsterdam Pharma Co N.V.). SUNation Energy, Inc. runs the higher net margin — 9.6% vs -90.7%, a 100.3% gap on every dollar of revenue. On growth, NewAmsterdam Pharma Co N.V. posted the faster year-over-year revenue change (740.1% vs 77.0%).

Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

Suncor Energy Inc. is a Canadian integrated energy company based in Calgary, Alberta. It specializes in production of synthetic crude from oil sands. In the 2020 Forbes Global 2000, Suncor Energy was ranked as the 48th-largest public company in the world.

NAMS vs SUNE — Head-to-Head

Bigger by revenue
SUNE
SUNE
1.4× larger
SUNE
$27.2M
$19.1M
NAMS
Growing faster (revenue YoY)
NAMS
NAMS
+663.1% gap
NAMS
740.1%
77.0%
SUNE
Higher net margin
SUNE
SUNE
100.3% more per $
SUNE
9.6%
-90.7%
NAMS

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
NAMS
NAMS
SUNE
SUNE
Revenue
$19.1M
$27.2M
Net Profit
$-17.4M
$2.6M
Gross Margin
40.7%
Operating Margin
-186.1%
10.7%
Net Margin
-90.7%
9.6%
Revenue YoY
740.1%
77.0%
Net Profit YoY
55.5%
138.2%
EPS (diluted)
$-0.15
$105.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NAMS
NAMS
SUNE
SUNE
Q4 25
$27.2M
Q3 25
$19.0M
Q2 25
$19.1M
$13.1M
Q1 25
$12.6M
Q4 24
$12.8M
$15.4M
Q3 24
$29.1M
$14.7M
Q2 24
$13.5M
Q1 24
$13.2M
Net Profit
NAMS
NAMS
SUNE
SUNE
Q4 25
$2.6M
Q3 25
$-393.0K
Q2 25
$-17.4M
$-9.6M
Q1 25
$-3.5M
Q4 24
$-92.2M
$-6.8M
Q3 24
$-16.6M
$-3.3M
Q2 24
$-6.9M
Q1 24
$1.2M
Gross Margin
NAMS
NAMS
SUNE
SUNE
Q4 25
40.7%
Q3 25
38.0%
Q2 25
37.0%
Q1 25
35.1%
Q4 24
36.4%
Q3 24
35.6%
Q2 24
35.4%
Q1 24
36.4%
Operating Margin
NAMS
NAMS
SUNE
SUNE
Q4 25
10.7%
Q3 25
-1.3%
Q2 25
-186.1%
-16.6%
Q1 25
-17.2%
Q4 24
-338.5%
-42.3%
Q3 24
-85.9%
-10.9%
Q2 24
-15.0%
Q1 24
-16.5%
Net Margin
NAMS
NAMS
SUNE
SUNE
Q4 25
9.6%
Q3 25
-2.1%
Q2 25
-90.7%
-73.5%
Q1 25
-27.7%
Q4 24
-721.7%
-44.4%
Q3 24
-57.2%
-22.4%
Q2 24
-51.2%
Q1 24
9.1%
EPS (diluted)
NAMS
NAMS
SUNE
SUNE
Q4 25
$105.59
Q3 25
$-0.12
Q2 25
$-0.15
$-3.14
Q1 25
$-106.71
Q4 24
$-0.91
$41676.94
Q3 24
$-0.18
$-2350.12
Q2 24
$-11022.91
Q1 24
$-38414.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NAMS
NAMS
SUNE
SUNE
Cash + ST InvestmentsLiquidity on hand
$739.2M
$7.2M
Total DebtLower is stronger
$6.6M
Stockholders' EquityBook value
$778.5M
$24.3M
Total Assets
$815.1M
$48.2M
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NAMS
NAMS
SUNE
SUNE
Q4 25
$7.2M
Q3 25
$5.4M
Q2 25
$739.2M
$3.2M
Q1 25
$1.4M
Q4 24
$834.2M
$839.3K
Q3 24
$422.7M
$1.1M
Q2 24
$1.0M
Q1 24
$1.8M
Total Debt
NAMS
NAMS
SUNE
SUNE
Q4 25
$6.6M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NAMS
NAMS
SUNE
SUNE
Q4 25
$24.3M
Q3 25
$21.7M
Q2 25
$778.5M
$22.1M
Q1 25
$14.8M
Q4 24
$757.5M
$8.5M
Q3 24
$378.9M
$13.1M
Q2 24
$-10.9M
Q1 24
$-11.2M
Total Assets
NAMS
NAMS
SUNE
SUNE
Q4 25
$48.2M
Q3 25
$49.6M
Q2 25
$815.1M
$44.1M
Q1 25
$44.4M
Q4 24
$864.6M
$45.7M
Q3 24
$439.2M
$51.0M
Q2 24
$52.9M
Q1 24
$54.7M
Debt / Equity
NAMS
NAMS
SUNE
SUNE
Q4 25
0.27×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NAMS
NAMS
SUNE
SUNE
Operating Cash FlowLast quarter
$-37.7M
$2.1M
Free Cash FlowOCF − Capex
$-37.8M
FCF MarginFCF / Revenue
-197.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.81×
TTM Free Cash FlowTrailing 4 quarters
$-119.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NAMS
NAMS
SUNE
SUNE
Q4 25
$2.1M
Q3 25
$2.4M
Q2 25
$-37.7M
$-130.2K
Q1 25
$-3.4M
Q4 24
$-37.5M
$-1.9M
Q3 24
$-12.5M
$-968.1K
Q2 24
$-776.4K
Q1 24
$-2.6M
Free Cash Flow
NAMS
NAMS
SUNE
SUNE
Q4 25
Q3 25
$2.4M
Q2 25
$-37.8M
Q1 25
Q4 24
$-37.5M
$-1.9M
Q3 24
$-12.6M
$-980.3K
Q2 24
$-788.4K
Q1 24
$-2.7M
FCF Margin
NAMS
NAMS
SUNE
SUNE
Q4 25
Q3 25
12.5%
Q2 25
-197.2%
Q1 25
Q4 24
-293.5%
-12.4%
Q3 24
-43.2%
-6.7%
Q2 24
-5.8%
Q1 24
-20.1%
Capex Intensity
NAMS
NAMS
SUNE
SUNE
Q4 25
Q3 25
0.0%
Q2 25
0.5%
Q1 25
Q4 24
0.0%
0.0%
Q3 24
0.3%
0.1%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
NAMS
NAMS
SUNE
SUNE
Q4 25
0.81×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NAMS
NAMS

Segment breakdown not available.

SUNE
SUNE

Transferred At Point In Time$15.1M55%
Hawaii Energy Connection$10.0M37%
Transferred Over Time$2.1M8%

Related Comparisons